Recent findings in chronic obstructive pulmonary disease by using quantitative computed tomography

Respiratory Investigation

Volumn 50, Issue 3, 2012, Pages 78-87

  Van Tho, Nguyen ^a,b   Wada, Hiroshi ^a   Ogawa, Emiko ^a   Nakano, Yasutaka ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b UNIVERSITY OF MEDICINE AND PHARMACY AT HO CHI MINH CITY   (Viet Nam)

Author keywords

Airway wall; Computed tomography; COPD; Emphysema; Quantitative imaging

Indexed keywords

GELATINASE B; GLUTATHIONE TRANSFERASE P1; TIOTROPIUM BROMIDE;

AIRWAY DYNAMICS; ARTERIAL STIFFNESS; ARTERIAL WALL THICKENING; ATHEROSCLEROSIS; CANCER RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; EMPHYSEMA; EPHX1 GENE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GSTP1 GENE; HUMAN; IMAGE ANALYSIS; LUNG BLOOD VESSEL; LUNG CANCER; LUNG RESECTION; MMP1 GENE; OSTEOPOROSIS; PHENOTYPE; PULMONARY HYPERTENSION; QUANTITATIVE ANALYSIS; RADIATION DOSE; RADIATION EXPOSURE; RESIDUAL VOLUME; REVIEW; SCORING SYSTEM; TOTAL LUNG CAPACITY;

EMPHYSEMA; HUMANS; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84875829977     PISSN: 22125345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resinv.2012.08.002     Document Type: Review

References (111)

1. World Health Organization The World health report 2004-changing history 2004, World Health Organization, Geneva, Available at: 〈http://www.who.int/whr/2004/en/〉 [accessed 28.03.12].
2. Murray C.J., Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 1997, 349:1498-1504.
3. The Global Strategy for the Diagnosis Management, and prevention of COPD 2011, Global Initiative for Chronic Obstructive Lung Disease (GOLD), Available at: 〈http://www.goldcopd.org〉 [accessed 28.03.012].
4. Hogg J.C., Chu F., Utokaparch S., et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004, 350:2645-2653.
5. Hogg J.C., Macklem P.T., Thurlbeck W.M. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med 1968, 278:1355-1360.
6. Hogg J.C. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004, 364:709-721.
7. Coxson H.O., Rogers R.M. Quantitative computed tomography of chronic obstructive pulmonary disease. Acad Radiol 2005, 12:1457-1463.
8. The definition of emphysema. Report of a National Heart, Lung, and Blood Institute, Division of Lung Diseases Workshop. Am Rev Respir Dis 1985;132:182-5.
9. Thurlbeck W.M., Muller N.L. Emphysema: definition, imaging, and quantification. AJR Am J Roentgenol 1994, 163:1017-1025.
10. Bergin C.J., Muller N.L., Miller R.R. CT in the qualitative assessment of emphysema. J Thorac Imaging 1986, 1:94-103.
11. Hansell D.M., Bankier A.A., MacMahon H., et al. Fleischner Society: glossary of terms for thoracic imaging. Radiology 2008, 246:697-722.
12. Bergin C., Muller N., Nichols D.M., et al. The diagnosis of emphysema. A computed tomographic-pathologic correlation. Am Rev Respir Dis 1986, 133:541-546.
13. Foster W.L., Pratt P.C., Roggli V.L., et al. Centrilobular emphysema: CT-pathologic correlation. Radiology 1986, 159:27-32.
14. Sakai N., Mishima M., Nishimura K., et al. An automated method to assess the distribution of low attenuation areas on chest CT scans in chronic pulmonary emphysema patients. Chest 1994, 106:1319-1325.
15. Goddard P.R., Nicholson E.M., Laszlo G., et al. Computed tomography in pulmonary emphysema. Clin Radiol 1982, 33:379-387.
16. Bankier A.A., De Maertelaer V., Keyzer C., et al. Pulmonary emphysema: subjective visual grading versus objective quantification with macroscopic morphometry and thin-section CT densitometry. Radiology 1999, 211:851-858.
17. Gevenois P.A., de Maertelaer V., De Vuyst P., et al. Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1995, 152:653-657.
18. Gevenois P.A., De Vuyst P., de Maertelaer V., et al. Comparison of computed density and microscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1996, 154:187-192.
19. Muller N.L., Staples C.A., Miller R.R., et al. Density mask. An objective method to quantitate emphysema using computed tomography. Chest 1988, 94:782-787.
20. Dirksen A., Dijkman J.H., Madsen F., et al. A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy. Am J Respir Crit Care Med 1999, 160:1468-1472.
21. Gould G.A., MacNee W., McLean A., et al. CT measurements of lung density in life can quantitate distal airspace enlargement-an essential defining feature of human emphysema. Am Rev Respir Dis 1988, 137:380-392.
22. Madani A., De Maertelaer V., Zanen J., et al. Pulmonary emphysema: radiation dose and section thickness at multidetector CT quantification-comparison with macroscopic and microscopic morphometry. Radiology 2007, 243:250-257.
23. Madani A., Van Muylem A., de Maertelaer V., et al. Pulmonary emphysema: size distribution of emphysematous spaces on multidetector CT images-comparison with macroscopic and microscopic morphometry. Radiology 2008, 248:1036-1041.
24. Madani A., Van Muylem A., Gevenois P.A. Pulmonary emphysema: effect of lung volume on objective quantification at thin-section CT. Radiology 2010, 257:260-268.
25. Madani A., Zanen J., de Maertelaer V., et al. Pulmonary emphysema: objective quantification at multi-detector row CT-comparison with macroscopic and microscopic morphometry. Radiology 2006, 238:1036-1043.
26. Gietema H.A., Muller N.L., Fauerbach P.V., et al. Quantifying the extent of emphysema: factors associated with radiologists' estimations and quantitative indices of emphysema severity using the ECLIPSE cohort. Acad Radiol 2011, 18:661-671.
27. Parr D.G., Stoel B.C., Stolk J., et al. Influence of calibration on densitometric studies of emphysema progression using computed tomography. Am J Respir Crit Care Med 2004, 170:883-890.
28. Moroni C., Mascalchi M., Camiciottoli G., et al. Comparison of spirometric-gated and -ungated HRCT in COPD. J Comput Assist Tomogr 2003, 27:375-379.
29. Orlandi I., Moroni C., Camiciottoli G., et al. Spirometric-gated computed tomography quantitative evaluation of lung emphysema in chronic obstructive pulmonary disease: a comparison of 3 techniques. J Comput Assist Tomogr 2004, 28:437-442.
30. Stoel B.C., Putter H., Bakker M.E., et al. Volume correction in computed tomography densitometry for follow-up studies on pulmonary emphysema. Proc Am Thorac Soc 2008, 5:919-924.
31. Boedeker K.L., McNitt-Gray M.F., Rogers S.R., et al. Emphysema: effect of reconstruction algorithm on CT imaging measures. Radiology 2004, 232:295-301.
32. Akira M., Toyokawa K., Inoue Y., et al. Quantitative CT in chronic obstructive pulmonary disease: inspiratory and expiratory assessment. AJR Am J Roentgenol 2009, 192:267-272.
33. Camiciottoli G., Bartolucci M., Maluccio N.M., et al. Spirometrically gated high-resolution CT findings in COPD: lung attenuation vs lung function and dyspnea severity. Chest 2006, 129:558-564.
34. Cerveri I., Dore R., Corsico A., et al. Assessment of emphysema in COPD: a functional and radiologic study. Chest 2004, 125:1714-1718.
35. Desai S.R., Hansell D.M., Walker A., et al. Quantification of emphysema: a composite physiologic index derived from CT estimation of disease extent. Eur Radiol 2007, 17:911-918.
36. Nakano Y., Muro S., Sakai H., et al. Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am J Respir Crit Care Med 2000, 162:1102-1108.
37. Nakano Y., Sakai H., Muro S., et al. Comparison of low attenuation areas on computed tomographic scans between inner and outer segments of the lung in patients with chronic obstructive pulmonary disease: incidence and contribution to lung function. Thorax 1999, 54:384-389.
38. Eda S., Kubo K., Fujimoto K., et al. The relations between expiratory chest CT using helical CT and pulmonary function tests in emphysema. Am J Respir Crit Care Med 1997, 155:1290-1294.
39. Kauczor H.U., Hast J., Heussel C.P., et al. CT attenuation of paired HRCT scans obtained at full inspiratory/expiratory position: comparison with pulmonary function tests. Eur Radiol 2002, 12:2757-2763.
40. Matsuoka S., Kurihara Y., Yagihashi K., et al. Quantitative assessment of peripheral airway obstruction on paired expiratory/inspiratory thin-section computed tomography in chronic obstructive pulmonary disease with emphysema. J Comput Assist Tomogr 2007, 31:384-389.
41. Yamashiro T., Matsuoka S., Bartholmai B.J., et al. Collapsibility of lung volume by paired inspiratory and expiratory CT scans: correlations with lung function and mean lung density. Acad Radiol 2010, 17:489-495.
42. Zaporozhan J., Ley S., Eberhardt R., et al. Paired inspiratory/expiratory volumetric thin-slice CT scan for emphysema analysis: comparison of different quantitative evaluations and pulmonary function test. Chest 2005, 128:3212-3220.
43. Dransfield M.T., Washko G.R., Foreman M.G., et al. Gender differences in the severity of CT emphysema in COPD. Chest 2007, 132:464-470.
44. Grydeland T.B., Dirksen A., Coxson H.O., et al. Quantitative computed tomography: emphysema and airway wall thickness by sex, age and smoking. Eur Respir J 2009, 34:858-865.
45. Lee Y.K., Oh Y.M., Lee J.H., et al. Quantitative assessment of emphysema, air trapping, and airway thickening on computed tomography. Lung 2008, 186:157-165.
46. Makita H., Nasuhara Y., Nagai K., et al. Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease. Thorax 2007, 62:932-937.
47. Ogawa E., Nakano Y., Ohara T., et al. Body mass index in male patients with COPD: correlation with low attenuation areas on CT. Thorax 2009, 64:20-25.
48. Grydeland T.B., Dirksen A., Coxson H.O., et al. Quantitative computed tomography measures of emphysema and airway wall thickness are related to respiratory symptoms. Am J Respir Crit Care Med 2010, 181:353-359.
49. Stolk J., Putter H., Bakker E.M., et al. Progression parameters for emphysema: a clinical investigation. Respir Med 2007, 101:1924-1930.
50. Tanabe N., Muro S., Hirai T., et al. Impact of exacerbations on emphysema progression in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011, 183:1653-1659.
51. Mohamed Hoesein F.A., de Hoop B., Zanen P., et al. CT-quantified emphysema in male heavy smokers: association with lung function decline. Thorax 2011, 66:782-787.
52. Haruna A., Muro S., Nakano Y., et al. CT scan findings of emphysema predict mortality in COPD. Chest 2010, 138:635-640.
53. Ohara T., Hirai T., Muro S., et al. Relationship between pulmonary emphysema and osteoporosis assessed by CT in patients with COPD. Chest 2008, 134:1244-1249.
54. Bon J., Fuhrman C.R., Weissfeld J.L., et al. Radiographic emphysema predicts low bone mineral density in a tobacco-exposed cohort. Am J Respir Crit Care Med 2011, 183:885-890.
55. de Torres J.P., Bastarrika G., Wisnivesky J.P., et al. Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest 2007, 132:1932-1938.
56. Zulueta J.J., Wisnivesky J.P., Henschke C.I., et al. Emphysema scores predict death from COPD and lung cancer. Chest 2012, 141:1216-1223.
57. Wilson D.O., Weissfeld J.L., Balkan A., et al. Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med 2008, 178:738-744.
58. Iwamoto H., Yokoyama A., Kitahara Y., et al. Airflow limitation in smokers is associated with subclinical atherosclerosis. Am J Respir Crit Care Med 2009, 179:35-40.
59. McAllister D.A., Maclay J.D., Mills N.L., et al. Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007, 176:1208-1214.
60. Nakano Y., Coxson H.O., Bosan S., et al. Core to rind distribution of severe emphysema predicts outcome of lung volume reduction surgery. Am J Respir Crit Care Med 2001, 164:2195-2199.
61. Revel M.P., Faivre J.B., Remy-Jardin M., et al. Automated lobar quantification of emphysema in patients with severe COPD. Eur Radiol 2008, 18:2723-2730.
62. Coxson H.O., Whittall K.P., Nakano Y., et al. Selection of patients for lung volume reduction surgery using a power law analysis of the computed tomographic scan. Thorax 2003, 58:510-514.
63. Rogers R.M., Coxson H.O., Sciurba F.C., et al. Preoperative severity of emphysema predictive of improvement after lung volume reduction surgery: use of CT morphometry. Chest 2000, 118:1240-1247.
64. Washko G.R., Martinez F.J., Hoffman E.A., et al. Physiological and computed tomographic predictors of outcome from lung volume reduction surgery. Am J Respir Crit Care Med 2010, 181:494-500.
65. Brenner D.J., Hall E.J. Computed tomography-an increasing source of radiation exposure. N Engl J Med 2007, 357:2277-2284.
66. Gierada D.S., Pilgram T.K., Whiting B.R., et al. Comparison of standard- and low-radiation-dose CT for quantification of emphysema. AJR Am J Roentgenol 2007, 188:42-47.
67. Koyama H., Ohno Y., Yamazaki Y., et al. Quantitative and qualitative assessments of lung destruction and pulmonary functional loss from reduced-dose thin-section CT in pulmonary emphysema patients. Acad Radiol 2010, 17:163-168.
68. Yuan R., Mayo J.R., Hogg J.C., et al. The effects of radiation dose and CT manufacturer on measurements of lung densitometry. Chest 2007, 132:617-623.
69. King G.G., Muller N.L., Whittall K.P., et al. An analysis algorithm for measuring airway lumen and wall areas from high-resolution computed tomographic data. Am J Respir Crit Care Med 2000, 161:574-580.
70. Yamashiro T., Matsuoka S., Estepar R.S., et al. Quantitative assessment of bronchial wall attenuation with thin-section CT: an indicator of airflow limitation in chronic obstructive pulmonary disease. AJR Am J Roentgenol 2010, 195:363-369.
71. Reinhardt J.M., D'Souza N.D., Hoffman E.A. Accurate measurement of intrathoracic airways. IEEE Trans Med Imaging 1997, 16:820-827.
72. Berger P., Perot V., Desbarats P., et al. Airway wall thickness in cigarette smokers: quantitative thin-section CT assessment. Radiology 2005, 235:1055-1064.
73. Saba O.I., Hoffman E.A., Reinhardt J.M. Maximizing quantitative accuracy of lung airway lumen and wall measures obtained from X-ray CT imaging. J Appl Physiol 2003, 95:1063-1075.
74. Tschirren J., Hoffman E.A., McLennan G., et al. Intrathoracic airway trees: segmentation and airway morphology analysis from low-dose CT scans. IEEE Trans Med Imaging 2005, 24:1529-1539.
75. Nakano Y., Wong J.C., de Jong P.A., et al. The prediction of small airway dimensions using computed tomography. Am J Respir Crit Care Med 2005, 171:142-146.
76. Orlandi I., Moroni C., Camiciottoli G., et al. Chronic obstructive pulmonary disease: thin-section CT measurement of airway wall thickness and lung attenuation. Radiology 2005, 234:604-610.
77. Hasegawa M., Nasuhara Y., Onodera Y., et al. Airflow limitation and airway dimensions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006, 173:1309-1315.
78. Montaudon M., Berger P., de Dietrich G., et al. Assessment of airways with three-dimensional quantitative thin-section CT: in vitro and in vivo validation. Radiology 2007, 242:563-572.
79. Palagyi K., Tschirren J., Hoffman E.A., et al. Quantitative analysis of pulmonary airway tree structures. Comput Biol Med 2006, 36:974-996.
80. Tschirren J., McLennan G., Palagyi K., et al. Matching and anatomical labeling of human airway tree. IEEE Trans Med Imaging 2005, 24:1540-1547.
81. Kim V., Han M.K., Vance G.B., et al. The chronic bronchitic phenotype of COPD: an analysis of the COPDGene study. Chest 2011, 140:626-633.
82. Ohara T., Hirai T., Sato S., et al. Comparison of airway dimensions in different anatomic locations on chest CT in patients with COPD. Respirology 2006, 11:579-585.
83. Coxson H.O., Quiney B., Sin D.D., et al. Airway wall thickness assessed using computed tomography and optical coherence tomography. Am J Respir Crit Care Med 2008, 177:1201-1206.
84. Matsuoka S., Kurihara Y., Yagihashi K., et al. Airway dimensions at inspiratory and expiratory multisection CT in chronic obstructive pulmonary disease: correlation with airflow limitation. Radiology 2008, 248:1042-1049.
85. Shimizu K., Hasegawa M., Makita H., et al. Comparison of airway remodelling assessed by computed tomography in asthma and COPD. Respir Med 2011, 105:1275-1283.
86. Achenbach T., Weinheimer O., Biedermann A., et al. MDCT assessment of airway wall thickness in COPD patients using a new method: correlations with pulmonary function tests. Eur Radiol 2008, 18:2731-2738.
87. Patel B.D., Coxson H.O., Pillai S.G., et al. Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008, 178:500-505.
88. Matsuoka S., Kurihara Y., Nakajima Y., et al. Serial change in airway lumen and wall thickness at thin-section CT in asymptomatic subjects. Radiology 2005, 234:595-603.
89. Ohara T., Hirai T., Sato S., et al. Longitudinal study of airway dimensions in chronic obstructive pulmonary disease using computed tomography. Respirology 2008, 13:372-378.
90. Vestbo J., Anderson W., Coxson H.O., et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J 2008, 31:869-873.
91. Hasegawa M., Makita H., Nasuhara Y., et al. Relationship between improved airflow limitation and changes in airway calibre induced by inhaled anticholinergic agents in COPD. Thorax 2009, 64:332-338.
92. Matsuoka S., Washko G.R., Dransfield M.T., et al. Quantitative CT measurement of cross-sectional area of small pulmonary vessel in COPD: correlations with emphysema and airflow limitation. Acad Radiol 2010, 17:93-99.
93. Matsuoka S., Washko G.R., Yamashiro T., et al. Pulmonary hypertension and computed tomography measurement of small pulmonary vessels in severe emphysema. Am J Respir Crit Care Med 2010, 181:218-225.
94. Matsuoka S., Yamashiro T., Diaz A., et al. The relationship between small pulmonary vascular alteration and aortic atherosclerosis in chronic obstructive pulmonary disease: quantitative CT analysis. Acad Radiol 2011, 18:40-46.
95. Boschetto P., Quintavalle S., Zeni E., et al. Association between markers of emphysema and more severe chronic obstructive pulmonary disease. Thorax 2006, 61:1037-1042.
96. Fujimoto K., Kitaguchi Y., Kubo K., et al. Clinical analysis of chronic obstructive pulmonary disease phenotypes classified using high-resolution computed tomography. Respirology 2006, 11:731-740.
97. Kitaguchi Y., Fujimoto K., Kubo K., et al. Characteristics of COPD phenotypes classified according to the findings of HRCT. Respir Med 2006, 100:1742-1752.
98. Tashkin D.P., Celli B., Senn S., et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008, 359:1543-1554.
99. Nakano Y., Muller N.L., King G.G., et al. Quantitative assessment of airway remodeling using high-resolution CT. Chest 2002, 122:271S-275S.
100. Boschetto P., Miniati M., Miotto D., et al. Predominant emphysema phenotype in chronic obstructive pulmonary. Eur Respir J 2003, 21:450-454.
101. Lee J.H., Lee Y.K., Kim E.K., et al. Responses to inhaled long-acting beta-agonist and corticosteroid according to COPD subtype. Respir Med 2010, 104:542-549.
102. Coxson H.O. Quantitative computed tomography assessment of airway wall dimensions: current status and potential applications for phenotyping chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008, 5:940-945.
103. Ito I., Nagai S., Hoshino Y., et al. Risk and severity of COPD is associated with the group-specific component of serum globulin 1F allele. Chest 2004, 125:63-70.
104. Kong X., Cho M.H., Anderson W., et al. Genome-wide association study identifies BICD1 as a susceptibility gene for emphysema. Am J Respir Crit Care Med 2011, 183:43-49.
105. Pillai S.G., Kong X., Edwards L.D., et al. Loci identified by genome-wide association studies influence different disease-related phenotypes in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010, 182:1498-1505.
106. Atkinson J.J., Lutey B.A., Suzuki Y., et al. The role of matrix metalloproteinase-9 in cigarette smoke-induced emphysema. Am J Respir Crit Care Med 2011, 183:876-884.
107. Ito I., Nagai S., Handa T., et al. Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema. Am J Respir Crit Care Med 2005, 172:1378-1382.
108. DeMeo D.L., Hersh C.P., Hoffman E.A., et al. Genetic determinants of emphysema distribution in the national emphysema treatment trial. Am J Respir Crit Care Med 2007, 176:42-48.
109. Hizawa N., Makita H., Nasuhara Y., et al. Functional single nucleotide polymorphisms of the CCL5 gene and nonemphysematous phenotype in COPD patients. Eur Respir J 2008, 32:372-378.
110. Haq I., Lowrey G.E., Kalsheker N., et al. Matrix metalloproteinase-12 (MMP-12) SNP affects MMP activity, lung macrophage infiltration and protects against emphysema in COPD. Thorax 2011, 66:970-976.
111. Kim W.J., Oh Y.M., Sung J., et al. CT scanning-based phenotypes vary with ADRB2 polymorphisms in chronic obstructive pulmonary disease. Respir Med 2009, 103:98-103.